Skip to content

Study · Non-randomized trial · n = 60 · 2015

2 results

[Clinical and electroencephalographic characteristics of specific language impairment in children and an evaluation of the efficacy of cerebrolysin].

Chutko LS, Surushkina SY, Yakovenko EA, Sergeev AV, Rozhkova AV, Anosova LV, Chistyakova NP

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2015Cited by 4 (Europe PMC)

PMID26356521 (opens in a new tab)DOI10.17116/jnevro20151157198-102 (opens in a new tab)PepBankPUB-26356521
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with specific language impairment, Cerebrolysin treatment produced improvement in 73.3% of cases.

    In plain wordsIn children with specific language impairment, Cerebrolysin treatment produced improvement in 73.3% of cases.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseClinical improvement
    Study

    n = 60

    Outcome group
    Speech and language · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Improvement
    73.3%
    specific language impairment

    Source sentences

    Summary
    The high efficacy of cerebrolysin in the treatment of this disease (an improvement was obtained in 73.3% of cases) was demonstrated, with the best effect in children with SLI-E (80.0% of cases).
    1 context sentence
    Summary · context
    Authors examined 60 children, aged 5-7 years, with a specific language impairment (SLI).
  2. 02HumanNon-randomized trialEfficacy outcome

    In children with expressive language impairment, Cerebrolysin treatment produced improvement in 80.0% of cases, the best reported subgroup effect.

    In plain wordsIn children with expressive language impairment, Cerebrolysin treatment produced improvement in 80.0% of cases.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseClinical improvement in SLI-E
    Study

    n: not reported in source

    Outcome group
    Speech and language · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Improvement
    80%
    SLI-E

    Source sentences

    Summary
    The high efficacy of cerebrolysin in the treatment of this disease (an improvement was obtained in 73.3% of cases) was demonstrated, with the best effect in children with SLI-E (80.0% of cases).
    1 context sentence
    Summary · context
    Authors examined 60 children, aged 5-7 years, with a specific language impairment (SLI).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.